Ling Zongxin, Liu Xia, Cheng Yiwen, Yan Xiumei, Wu Shaochang
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Department of Intensive Care Unit, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Crit Rev Food Sci Nutr. 2022;62(13):3509-3534. doi: 10.1080/10408398.2020.1867054. Epub 2020 Dec 30.
Aging is characterized by the functional decline of tissues and organs and increased risk of aging-associated disorders, which pose major societal challenges and are a public health priority. Despite extensive human genetics studies, limited progress has been made linking genetics with aging. There is a growing realization that the altered assembly, structure and dynamics of the gut microbiota actively participate in the aging process. Age-related microbial dysbiosis is involved in reshaping immune responses during aging, which manifest as immunosenescence (insufficiency) and inflammaging (over-reaction) that accompany many age-associated enteric and extraenteric diseases. The gut microbiota can be regulated, suggesting a potential target for aging interventions. This review summarizes recent findings on the physiological succession of gut microbiota across the life-cycle, the roles and mechanisms of gut microbiota in healthy aging, alterations of gut microbiota and aging-associated diseases, and the gut microbiota-targeted anti-aging strategies.
衰老的特征是组织和器官功能衰退以及与衰老相关疾病的风险增加,这给社会带来了重大挑战,也是公共卫生的重点。尽管进行了广泛的人类遗传学研究,但在将遗传学与衰老联系起来方面进展有限。人们越来越认识到,肠道微生物群的组装、结构和动态变化积极参与了衰老过程。与年龄相关的微生物失调参与了衰老过程中免疫反应的重塑,表现为免疫衰老(功能不足)和炎症衰老(过度反应),这与许多与年龄相关的肠道和肠道外疾病相伴相随。肠道微生物群是可以调节的,这表明它是衰老干预的一个潜在靶点。本综述总结了关于肠道微生物群在整个生命周期中的生理演替、肠道微生物群在健康衰老中的作用和机制、肠道微生物群的改变与衰老相关疾病,以及针对肠道微生物群的抗衰老策略的最新研究结果。